Shashikant Nagre
Manager, Upstream Process Development at Akston Biosciences Corporation - Beverly, MA, US
Shashikant Nagre's Colleagues at Akston Biosciences Corporation
Shashikant Nagre's Contact Details
N/A
316 Huntington Avenue,Boston,Massachusetts,02115,United States
Akston Biosciences Corporation
Shashikant Nagre's Company Details
Akston Biosciences Corporation leverages its novel fusion protein platform to develop and manufacture new classes of biologics, including vaccines, ultra-long-acting insulins, and autoimmune disease therapies. Founded by the team that developed the world's first clinical glucose-responsive insulin at SmartCells, Inc., Akston's COVID-19 vaccine candidate is in Phase II trials in the Netherlands. It has partnered with Dechra Pharmaceuticals PLC to commercialize once-a-week canine and feline insulin therapies. The company employs 35 people, has over 3,500 ft2 of research laboratory space and a 12,400 ft2 GMP clean room biologics manufacturing facility.